He Huang, MD
First Affiliated Hospital of Zhejiang University · Zhejiang University · The Second Affiliated Hospital, Chongqing Medical University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name He Huang, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:49 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07257640 · IL-5 CAR-T Cell Therapy for Refractory/Relapsed Eosinophilic LeukemiaZhejiang University · recruiting · Hematologic Diseases, Neoplasms · principal investigator
- Ph1NCT07246707 · KSV01 Injection as the Therapy for Relapsed/Refractory B-Cell Acute Lymphoblastic LeukemiaZhejiang University · recruiting · B-ALL · principal investigator
- Early Ph1NCT07144020 · Donor Derived CD117 CAR-T Cells in the Treatment of R/R Acute Myeloid LeukemiaZhejiang University · recruiting · Acute Myeloid Leukemia · principal investigator
- Early Ph1NCT06793241 · Donor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic LeukemiaZhejiang University · recruiting · B-cell Acute Lymphoblastic Leukemia · principal investigator
- Early Ph1NCT06787560 · CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System DiseasesZhejiang University · recruiting · Bone Marrow Failure Syndrome · principal investigator
- Early Ph1NCT06785519 · CD19/BCMA CAR-T Cell Therapy for Refractory/Relapsed Lupus NephritisHe Huang · recruiting · Lupus Nephritis · principal investigator
- Early Ph1NCT06769191 · Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell Sequential Allo-HSCT and Kidney Transplantation in the Treatment of SIODZhejiang University · recruiting · Schimke Immuno-osseous Dysplasia · principal investigator
- Early Ph1NCT06762132 · A Clinical Study to Explore the Safety and Efficacy of CD33 CAR-T Cell in Relapsed/Refractory Acute Myeloid LeukemiaZhejiang University · recruiting · Acute Myeloid Leukemia · principal investigator
- Early Ph1NCT06633354 · Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-ALLZhejiang University · recruiting · T-Acute Lymphoblastic Leukemia · principal investigator
- Early Ph1NCT06633328 · CD7 CAR-T Bridging to alloHSCT for Severe Aplastic AnemiaZhejiang University · recruiting · Aplastic Anemia · principal investigator
- Early Ph1NCT06633341 · Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-lymphomaZhejiang University · recruiting · T-lymphoblastic Lymphoma · principal investigator
- Ph1NCT06367673 · Natural Killer(NK) Cell Therapy Targeting CLL1 or CD33 in Acute Myeloid LeukemiaZhejiang University · unknown · AML, Adult · principal investigator
- Early Ph1NCT06346912 · CD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHLZhejiang University · recruiting · Acute Lymphoblastic Leukemia,B-Cell, Non-hodgkin Lymphoma,B Cell · principal investigator
- Early Ph1NCT06279923 · CD19-BAFF CAR-T Cells Therapy for Patients With Autoimmune DiseasesZhejiang University · recruiting · Autoimmune Diseases · principal investigator
- N/ANCT06165757 · The Effects of Non Harmonic and White Noise on Human Pain Sensitivity: a Study of Healthy VolunteersThe Second Affiliated Hospital of Chongqing Medical University · completed · Pain · principal investigator
- Ph1/Ph2NCT06118788 · Phase I Clinical Study: BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid LeukemiaGuangzhou Bio-gene Technology Co., Ltd · recruiting · Leukemia, Myeloid, Acute · principal investigator
- Ph1NCT06084962 · A Study of DeepTag-GPRC5D Targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple MyelomaHe Huang · unknown · Relapse/Refractory Multiple Myeloma · principal investigator
- Ph1NCT06027853 · Natural Killer(NK) Cell Therapy Targeting CLL1 in Acute Myeloid LeukemiaZhejiang University · unknown · AML, Adult · principal investigator
- Ph1NCT05828212 · Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of R/R Neuromyelitis OpticaZhejiang University · completed · Neuromyelitis Optica · principal investigator
- Ph1/Ph2NCT05827835 · CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic DiseasesZhejiang University · recruiting · Hematologic Diseases, Neoplasms · principal investigator
- Ph1NCT05828225 · Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of Refractory Myasthenia GravisZhejiang University · unknown · Myasthenia Gravis · principal investigator
- Ph1NCT05740891 · AHSCT Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Multiple MyelomaZhejiang University · unknown · Multiple Myeloma · principal investigator
- Ph2NCT05712083 · A Study of BCMA CAR-T Cell Therapy for Newly Diagnosed Multiple MyelomaZhejiang University · unknown · Multiple Myeloma, New Diagnosis Tumor · principal investigator
- N/ANCT05529212 · Cardiac Surgery and Postoperative Organ DysfunctionThe Second Affiliated Hospital of Chongqing Medical University · unknown · Postoperative Complications · principal investigator
- Ph1NCT05473221 · Evaluate the Safety and Efficacy of CD33 CAR-T in Patients With R/R AMLZhejiang University · unknown · AML · principal investigator
- Ph1NCT05467254 · Evaluate the Safety and Efficacy of CLL1+CD33 CAR-T in Patients With R/R AMLZhejiang University · unknown · AML · principal investigator
- Ph1NCT05467202 · Evaluate the Safety and Efficacy of CLL1 CAR-T in Patients With R/R AMLZhejiang University · unknown · AML · principal investigator
- Ph1NCT05463640 · Evaluate the Safety and Efficacy of ADGRE2 CAR-T in Patients With R/R AMLZhejiang University · unknown · AML · principal investigator
- N/ANCT05392426 · Left Ventricular Global Longitudinal Strain and Postoperative Myocardial InjuryThe Second Affiliated Hospital of Chongqing Medical University · unknown · Postoperative Complications · principal investigator
- N/ANCT05356520 · Comparison of Different Operations for Siewert Type II Adenocarcinoma of Esophagogastric JunctionXijing Hospital of Digestive Diseases · recruiting · Siewert Type II Adenocarcinoma of Esophagogastric Junction · principal investigator
- Ph4NCT05331651 · Effect of Glycopyrronium in Combination With Tropisetron in Anti-postoperative Nausea and VomitingThe Second Affiliated Hospital of Chongqing Medical University · completed · Postoperative Nausea and Vomiting · principal investigator
- Ph4NCT05265507 · Comparison of Postoperative Anti-nausea and Vomiting Effect Between Glycopyrronium and OndansetronThe Second Affiliated Hospital of Chongqing Medical University · unknown · Postoperative Nausea and Vomiting · principal investigator
- Ph1NCT04516551 · Anti-CD19 Allo-CAR-T Cells for Relapsed B Cell Malignancies After HSCTXinqiao Hospital of Chongqing · unknown · Relapsed Adult ALL, B Cell Leukemia · principal investigator
- Ph2NCT02098629 · Concomitant Milrinone and Esmolol Treatment in Patients with Acute Myocardial InfarctionShantou University Medical College · completed · Myocardial Reperfusion Injury · study director
- Ph2/Ph3NCT01526850 · Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Chronic Graft Versus Host DiseaseChinese Academy of Medical Sciences · unknown · Chronic Graft Versus Host Disease · principal investigator
- Ph4NCT01198236 · Efficacy of Itraconazole as Secondary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation or Chemotherapy With Prior Invasive Fungal InfectionZhejiang University · completed · Invasive Fungal Infection · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:49 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.